[1]
V. Kumar and B. K. Panda, “CAN COST OF PHARMACOLOGICAL THROMBOLYTIC THERAPY BE A MEDICATION MANAGEMENT STRATEGY FOR ACUTE CORONARY SYNDROME?”, Asian J Pharm Clin Res, vol. 10, no. 3, pp. 363-366, Mar. 2017.